Clinical Trial Update: Exploration of the Efficacy and Mechanism of Galantamine (an Extract From Lycoris Aurea) in Treating Ischemic Stroke [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial is investigating the efficacy and mechanism of galantamine, derived from Lycoris aurea, for treating acute ischemic stroke and is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Galantamine (galantamine)

Snippet

Sponsor: Shanghai Yueyang Integrated Medicine Hospital | Conditions: Acute Ischemic Stroke AIS | Phase 2, Phase 3 | Status: RECRUITING